Lenacapavir, a new injectable drug that prevents HIV infection, has been recognized as the ‘Achievement of the Year’ for 2024 by Science magazine. Despite decades of advancements, HIV continues to infect over a million people annually. This new drug offers hope, providing six months of protection after each injection. Clinical trials showed remarkable efficacy, especially among adolescents and women in Africa. While regulatory approval is anticipated by 2025, global success hinges on affordability and robust health infrastructure.

Source